Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide ...
Background and Aim: Since the diagnostic value of ileoscopy is not well documented, it is uncertain if terminal ileum intubation should be performed routinely in patients undergoing colonoscopy.
NANJING, China--(BUSINESS WIRE)--Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent ...
Triastek advances 3D printed drug D23 - a delayed-release budesonide tablet produced using Triastek’s proprietary MED - for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果